Comments: NJ A2544 | 2022-2023 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-02-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2544 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A2544 at this time.

Social Comments on NJ A2544

feedback